iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
Type 1 Diabetes MellitusEating Disorders
Interventions
BEHAVIORAL

Therapy with Mobile App Enhancement

"Treatment includes 12 weekly therapy sessions with daily RR app use between sessions. Intervention is CBT-based and specifically draws from ACT. ACT is a contextual behavior therapy that emphasizes the function of behavior (e.g., affect regulation) and helps individuals accept (or tolerate) emotional discomfort for a broader purpose (i.e., personal values). Broadly, treatment will focus on improving diabetes management by increasing patients' capacity to effectively cope with psychological barriers to self-care using acceptance and mindfulness strategies."

Trial Locations (2)

27710

Duke University Health System, Durham

27713

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Duke University

OTHER